News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
85,581 Results
Type
Article (17347)
Company Profile (32)
Press Release (68192)
Multimedia
Podcasts (106)
Webinars (15)
Section
Business (30192)
Career Advice (915)
Deals (4779)
Drug Delivery (66)
Drug Development (8820)
Employer Resources (67)
FDA (1323)
Job Trends (2223)
News (40225)
Policy (2809)
Tag
2025 Best Places to Work (3)
2026 Best Places to Work (5)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Standard (2)
2027 Genetown Standard (3)
2027 Pharm Country Standard (2)
40 Under 40 (4)
Academia (268)
Accelerated approval (13)
ADA (6)
Adcomms (17)
Allergies (34)
Alliances (7219)
ALS (56)
Alzheimer's disease (282)
Antibody-drug conjugate (ADC) (206)
Approvals (1135)
Artificial intelligence (262)
ASCO (61)
Autoimmune disease (128)
Automation (16)
Bankruptcy (62)
Belgium (7)
Best Places to Work (890)
BIO (41)
Biologics (24)
BIOSECURE Act (17)
Biosimilars (48)
BioSpace Insights (87)
Biotechnology (27)
Bispecific (7)
Bladder cancer (42)
Brain cancer (24)
Breast cancer (92)
Cancer (1294)
Cardiovascular disease (148)
Career advice (784)
Career pathing (37)
CAR-T (138)
CDC (7)
CDMO (110)
Cell-line development (1)
Cell therapy (347)
Cervical cancer (10)
Clinical research (7328)
Collaboration (724)
Commercialization (14)
Company closure (7)
Compensation (48)
Complete response letters (54)
COVID-19 (444)
CRISPR (30)
CRO (6)
C-suite (528)
Cystic fibrosis (30)
Data (1083)
Decentralized trials (1)
Denatured (27)
Depression (54)
Dermatology (29)
Diabetes (70)
Diagnostics (580)
Digital health (5)
Diversity (4)
Diversity, equity & inclusion (19)
Drug discovery (172)
Drug pricing (51)
Drug shortages (1)
Duchenne muscular dystrophy (110)
Earnings (5594)
Editorial (42)
Employer branding (8)
Employer resources (70)
ESMO (55)
Events (11863)
Executive appointments (403)
Eye disease (7)
FDA (1789)
Fragile X (2)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (695)
Gene editing (83)
Generative AI (30)
Gene therapy (336)
GLP-1 (291)
Government (517)
Grass and pollen (1)
Guidances (30)
Healthcare (1226)
Hematology (35)
HIV (13)
Huntington's disease (40)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (33)
Immunology and inflammation (185)
Immuno-oncology (48)
Indications (26)
Infectious disease (538)
Inflammatory bowel disease (49)
Inflation Reduction Act (3)
Influenza (25)
Intellectual property (57)
Interviews (145)
IPO (1757)
IRA (11)
Job creations (1136)
Job search strategy (676)
JPM (46)
Kidney cancer (5)
Kidney disease (32)
Labor market (96)
Layoffs (287)
Leadership (42)
Legal (714)
Licensing (35)
Liver cancer (12)
Longevity (14)
Lung cancer (166)
Lung diease (5)
Lymphoma (65)
Machine learning (25)
Management (22)
Manufacturing (428)
Marketing (2)
MASH (50)
Medical affairs (1)
Medical device (381)
Medtech (390)
Melanoma (94)
Mergers & acquisitions (3181)
Metabolic disorders (384)
Middle East (2)
mRNA (106)
Multiple sclerosis (25)
Multispecific (3)
NASH (7)
Netherlands (4)
Neurodegenerative disease (173)
Neuropsychiatric disorders (54)
Neuroscience (727)
Neurotech (2)
NextGen: Class of 2026 (895)
Non-profit (279)
Now hiring (64)
Obesity (235)
Opinion (224)
Ovarian cancer (37)
Pain (30)
Pancreatic cancer (63)
Parkinson's disease (73)
Partnered (15)
Patents (108)
Patient recruitment (119)
Patient selection (17)
Peanut (6)
People (11429)
Peptides (11)
Pharmaceutical (8)
Phase 1 (2728)
Phase 2 (3513)
Phase 3 (2246)
Pipeline (1747)
Policy (164)
Postmarket research (114)
Preclinical (1026)
Press Release (53)
Prostate cancer (43)
Psychedelics (52)
Radiopharmaceuticals (90)
Rare diseases (492)
Real estate (1509)
Recruiting (40)
Regenerative medicine (8)
Regulatory (2751)
Reports (21)
Research institute (305)
Resumes & cover letters (154)
Rett syndrome (6)
RNA editing (17)
RSV (19)
Saudi Arabia (1)
Schizophrenia (37)
Series A (157)
Series B (94)
Series C (1)
Service/supplier (2)
Sickle cell disease (26)
Special edition (24)
Spinal muscular atrophy (19)
Sponsored (16)
Startups (1288)
Stem cells (3)
Stomach cancer (7)
Substance use disorders (8)
Supply chain (30)
Switzerland (8)
Tariffs (38)
Tax incentives (2)
The Weekly (78)
Vaccines (305)
Venture capital (159)
Weight loss (162)
Wet AMD (1)
Women's health (36)
Women in leadership (2)
Worklife (13)
Date
Today (21)
Last 7 days (104)
Last 30 days (494)
Last 365 days (4876)
2026 (4479)
2025 (4860)
2024 (5181)
2023 (5129)
2022 (6196)
2021 (6462)
2020 (4987)
2019 (4063)
2018 (3347)
2017 (4131)
2016 (3750)
2015 (4178)
2014 (5708)
2013 (6399)
2012 (2422)
2011 (2493)
2010 (2072)
Location
Africa (276)
Alabama (13)
Alaska (2)
Arizona (57)
Arkansas (2)
Asia (7700)
Australia (1205)
California (1826)
Canada (685)
China (564)
Colorado (58)
Connecticut (63)
Delaware (76)
Europe (18623)
Florida (283)
Georgia (34)
Hawaii (1)
Idaho (5)
Illinois (73)
India (22)
Indiana (54)
Iowa (6)
Japan (152)
Kansas (11)
Kentucky (7)
Louisiana (4)
Maine (1)
Maryland (264)
Massachusetts (1515)
Michigan (28)
Minnesota (37)
Mississippi (1)
Missouri (24)
Montana (6)
Nebraska (4)
Nevada (32)
New Hampshire (3)
New Jersey (621)
New Mexico (6)
New York (492)
North Carolina (293)
North Dakota (2)
Northern California (847)
Ohio (64)
Oklahoma (8)
Oregon (9)
Pennsylvania (456)
Puerto Rico (1)
Rhode Island (18)
South America (295)
South Carolina (5)
Southern California (770)
Tennessee (13)
Texas (285)
United States (6407)
Utah (50)
Virginia (31)
Washington D.C. (18)
Washington State (94)
West Virginia (1)
Wisconsin (30)
85,581 Results for "microvi biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Biotech’s boardroom gains for women fail to translate to CEO roles
Women held 29% of biotech board seats in fiscal year 2025 but just 8.8% of CEO roles, highlighting uneven progress across industry leadership spots.
November 17, 2026
·
1 min read
·
Gabrielle Masson
Layoffs
9 biotechs will cut at least half their California workforces
Workforce reductions have hit over 1,000 biopharma employees in The Golden State year to date, with pink slips coming from small biotechs and large pharmas. Biotechs have been hit the hardest, with nine companies saying goodbye to at least half their staffs.
November 19, 2026
·
6 min read
·
Angela Gabriel
Government
Government actions are hitting smaller biotechs the hardest: Report
Layoffs at the FDA, disruptions to research funding and increased tariffs led the investment banking firm Cassel Salpeter to wonder whether the government is strangling the biotech industry.
November 18, 2026
·
2 min read
·
Nick Paul Taylor
IPO
2026 IPO stock tracker: How newly public biotechs are performing
BioSpace
is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026.
November 18, 2026
·
1 min read
·
Gabrielle Masson
Drug Development
Can Saudi Arabia’s burgeoning biotech hub withstand geopolitical pressures?
Saudi Arabia is building the regulatory framework, partnerships infrastructure and IP landscape needed to support a biotech ecosystem, despite regional political instability. Whether it can produce sustainable biotech companies and a resilient manufacturing base for global production remains an open question, but the future looks bright.
November 2, 2026
·
6 min read
·
Jennifer C. Smith-Parker
IPO
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
Two RNA biotechs, ADARx Pharmaceuticals and City Therapeutics, are taking advantage of the IPO frenzy, which has led to a total of 27 newly public biotechs so far this year.
September 25, 2026
·
2 min read
·
Gabrielle Masson
Job Trends
Ramping up: 3 biotechs growing their workforce after series C raises
Biotechs that announced series C financing this year and are hiring include one that secured $140 million and has locations in London and Massachusetts.
November 19, 2026
·
4 min read
·
Angela Gabriel
Press Releases
Danish company biosuite introduces biotech procurement software to track outsourced R&D commitments
Founded by a former biotech finance professional, biosuite helps smaller biotech teams track financial commitments to research partners before the corresponding invoices arrive.
October 12, 2026
·
1 min read
China
BIO pitches US plan to beat China in biotech ‘space race’
The seven proposals in the Bio Advance plan include easing clinical trial starts, boosting manufacturing and establishing a new White House office to coordinate the government’s biotech policy.
November 10, 2026
·
2 min read
·
Annalee Armstrong
Funding
T-time: British biotech pours $133M into the pot for bispecifics
With backing from three Big Pharma investment arms, British biotech T-Therapeutics is brewing up a clinical launch for its cancer and autoimmune T cell engagers.
November 5, 2026
·
2 min read
·
Gabrielle Masson
1 of 8,559
Next